പങ്കിടുക
 
Comments

A Memorandum of Understanding (MOU) has been signed today in the presence of Chief Minister Narendra Modi between the public ventures of Gujarat government -- Gujarat Industrial Development Corporation (GIDC); Gujarat Infrastructure Development Board (GIDB); INDEXT-B – and Japan External Trade Organization (JETRO) to set up special Japanese industrial zone near Ahmedabad.

A high-level delegation of JETRO today called on Chief Minister Narendra Modi at his residence in Gandhinagar. Giving details of the MOU, President of JETRO Mr. Hideihiro Yokoo said that GIDC will develop a special Japanese industrial zone near Ahmedabad. Designing, infrastructural facilities and the subsequent vision of the industrial zone will be developed by GIDB, whereas INDEXT-B will handle the work of facilitating the Japanese investors and delegations of various Japanese companies in Gujarat.

Besides, various investment promotion seminars will also be arranged in Japan. JETRO will also play a central role in acquainting Japanese companies about the opportunities of investing in Gujarat considering the approaching Vibrant Gujarat Global Investors’ Summit-2013.

Welcoming the signing of this MOU as a landmark move Chief Minister said that partnership between Japan and Gujarat is growing in a big way with the development of Delhi-Mumabi Industrial Corridor and the Dholera SIR. Japan has also planned an ‘eco-friendly city’ in Sanand and Changodar. JETRO’s ties with Gujarat will prove beneficial to both the parties.

Minister of State for Industries Saurabh Patel, Principal Secretary for Industries Maheshwar Sahu, Principal Secretary to Chief Minister K.Kailasnathan, Secretary Mr. A. K. Sharma, MD of INDEXT-B Mukesh Kumar and Industries Commissioner B B Swain were also present on the occasion.

Pariksha Pe Charcha with PM Modi
Explore More
നടന്നു പോയിക്കോളും എന്ന മനോഭാവം മാറ്റാനുള്ള സമയമാണിത്, മാറ്റം വരുത്താനാവും എന്ന് ചിന്തിക്കുക: പ്രധാനമന്ത്രി മോദി

ജനപ്രിയ പ്രസംഗങ്ങൾ

നടന്നു പോയിക്കോളും എന്ന മനോഭാവം മാറ്റാനുള്ള സമയമാണിത്, മാറ്റം വരുത്താനാവും എന്ന് ചിന്തിക്കുക: പ്രധാനമന്ത്രി മോദി
9,200 oxygen concentrators, 5,243 O2 cylinders, 3.44L Remdesivir vials delivered to states: Govt

Media Coverage

9,200 oxygen concentrators, 5,243 O2 cylinders, 3.44L Remdesivir vials delivered to states: Govt
...

Nm on the go

Always be the first to hear from the PM. Get the App Now!
...
Prime Minister reviews availability & supply of oxygen and medicines
May 12, 2021
പങ്കിടുക
 
Comments
GoI is in regular touch with the manufacturers to enhance production of medicines & extend all help needed
Production of all drugs including Remdesivir have been ramped up significantly in the last few weeks
Supply of oxygen is now more than 3 times the supply during the peak of first wave

PM Narendra Modi chaired a high level meeting to review the availability & supply of oxygen & medicines.

PM was briefed that the Government is actively monitoring the supply of drugs being used in the management of Covid as well Mucormycosis. The Minister updated PM that they are in regular touch with the manufacturers to enhance production & extend all kind of help needed. PM was also informed about the current production & stock of APIs for each such drug. It was discussed that states are being provided medicines in good quantities. PM was also apprised that the production of all drugs including Remdesivir have been ramped up significantly in the last few weeks. PM said that India has a very vibrant Pharma sector and Government’s continued close coordination with them will ensure proper availability of all medicines.

PM also took stock of the situation on oxygen availability and supply in the country. It was discussed that the supply of oxygen is now more than 3 times the supply during the peak of first wave. PM was briefed about the operations of oxygen rail and sorties by IAF planes. PM was also informed about the status of procurement of Oxygen concentrators, oxygen cylinders as well as the status of PSA plants being installed across the country.

PM also remarked that states should be asked to operationalize ventilators in a time-bound manner and resolve technical & training issues with the help of the manufacturers.